[go: up one dir, main page]

WO2007031845A3 - Formes polymorphiques de sels de magnesium de (s)-omeprazole et procedes de preparation desdites formes - Google Patents

Formes polymorphiques de sels de magnesium de (s)-omeprazole et procedes de preparation desdites formes Download PDF

Info

Publication number
WO2007031845A3
WO2007031845A3 PCT/IB2006/002520 IB2006002520W WO2007031845A3 WO 2007031845 A3 WO2007031845 A3 WO 2007031845A3 IB 2006002520 W IB2006002520 W IB 2006002520W WO 2007031845 A3 WO2007031845 A3 WO 2007031845A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
processes
magnesium salts
polymorphic forms
omeprazole magnesium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2006/002520
Other languages
English (en)
Other versions
WO2007031845A2 (fr
Inventor
Bobba Venkata Siva Kumar
Pravin Bhalchandra Kulkarni
Changdev Namdev Raut
Anil Ganpat Suryawanshi
Nitin Sharad Chandra Pradhan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glenmark Pharmaceuticals Ltd
Original Assignee
Glenmark Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Ltd filed Critical Glenmark Pharmaceuticals Ltd
Publication of WO2007031845A2 publication Critical patent/WO2007031845A2/fr
Publication of WO2007031845A3 publication Critical patent/WO2007031845A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne de nouveaux polymorphes d'un sel de magnésium de (S)-oméprazole trihydrate et des procédés pour préparer ces polymorphes. Cette invention concerne également un procédé de préparation d'une forme amorphe d'un sel de magnésium de (S)-oméprazole. Ladite invention se rapporte en outre à des compositions pharmaceutiques contenant ces sels de magnésium.
PCT/IB2006/002520 2005-09-14 2006-09-13 Formes polymorphiques de sels de magnesium de (s)-omeprazole et procedes de preparation desdites formes Ceased WO2007031845A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1110/MUM/2005 2005-09-14
IN1110MU2005 2005-09-14
US75393105P 2005-12-23 2005-12-23
US60/753,931 2005-12-23

Publications (2)

Publication Number Publication Date
WO2007031845A2 WO2007031845A2 (fr) 2007-03-22
WO2007031845A3 true WO2007031845A3 (fr) 2007-05-18

Family

ID=37714230

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/002520 Ceased WO2007031845A2 (fr) 2005-09-14 2006-09-13 Formes polymorphiques de sels de magnesium de (s)-omeprazole et procedes de preparation desdites formes

Country Status (1)

Country Link
WO (1) WO2007031845A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009074997A2 (fr) * 2007-12-10 2009-06-18 Lee Pharma Ltd. Nouveau procédé de préparation de sel de magnésium cristallin de (s)-oméprazole dihydraté
WO2009099933A2 (fr) * 2008-02-01 2009-08-13 Dr. Reddy's Laboratories Ltd. Préparation de magnésium d’ésoméprazole et de ses hydrates
EP2147918A1 (fr) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Procédé de préparation de magnésium d'oméprazole S dans une forme stable
FR2959509B1 (fr) 2010-05-03 2012-07-13 Prod Chim Auxiliaires Et De Synthese Phase precurseur et son utilisation pour preparer le sel de magnesium tetrahydrate d'un enantiomere d'omeprazole
CN102911158B (zh) * 2011-07-31 2015-07-22 连云港润众制药有限公司 埃索美拉唑镁的晶型
CN103509001B (zh) * 2012-06-15 2016-12-21 石药集团中奇制药技术（石家庄）有限公司 一种埃索美拉唑镁三水合物及其制备方法
CN105936632A (zh) * 2016-05-23 2016-09-14 江苏中邦制药有限公司 三水合埃索美拉唑镁粗品的精制方法
CN116102538B (zh) * 2023-01-29 2024-10-18 山东省分析测试中心 一种转晶制备三水合艾司奥美拉唑镁的方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994027988A1 (fr) * 1993-05-28 1994-12-08 Astra Aktiebolag Sels optiquement purs de composes de pyridinylmethyle sylfinyl-ih-benzimidazole
WO1998054171A1 (fr) * 1997-05-30 1998-12-03 Astra Aktiebolag Nouvelle forme de s-omeprazole
WO2004020436A1 (fr) * 2002-08-30 2004-03-11 Reddy's Laboratories Limited Hydrates amorphes d'esomeprazole magnesium et leur procede de preparation
WO2004037253A1 (fr) * 2002-10-22 2004-05-06 Ranbaxy Laboratories Limited Forme amorphe de sels d'esomeprazole
WO2004046134A2 (fr) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Composes d'esomeprazole cristallins et procede permettant de preparer ces composes
WO2004089935A1 (fr) * 2003-04-10 2004-10-21 Hetero Drugs Limitd Nouvelles formes cristallines de s-omeprazole magnesium
WO2005118567A2 (fr) * 2004-05-28 2005-12-15 Aaipharma Inc. Complexes de magnesium s-omeprazole

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994027988A1 (fr) * 1993-05-28 1994-12-08 Astra Aktiebolag Sels optiquement purs de composes de pyridinylmethyle sylfinyl-ih-benzimidazole
WO1998054171A1 (fr) * 1997-05-30 1998-12-03 Astra Aktiebolag Nouvelle forme de s-omeprazole
WO2004020436A1 (fr) * 2002-08-30 2004-03-11 Reddy's Laboratories Limited Hydrates amorphes d'esomeprazole magnesium et leur procede de preparation
WO2004037253A1 (fr) * 2002-10-22 2004-05-06 Ranbaxy Laboratories Limited Forme amorphe de sels d'esomeprazole
WO2004046134A2 (fr) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Composes d'esomeprazole cristallins et procede permettant de preparer ces composes
WO2004089935A1 (fr) * 2003-04-10 2004-10-21 Hetero Drugs Limitd Nouvelles formes cristallines de s-omeprazole magnesium
WO2005118567A2 (fr) * 2004-05-28 2005-12-15 Aaipharma Inc. Complexes de magnesium s-omeprazole

Also Published As

Publication number Publication date
WO2007031845A2 (fr) 2007-03-22

Similar Documents

Publication Publication Date Title
WO2007031845A3 (fr) Formes polymorphiques de sels de magnesium de (s)-omeprazole et procedes de preparation desdites formes
IL185419A0 (en) Improved process for the synthesis of enantiomeric indanylamine derivatives
IL216449A0 (en) Process for the preparation of tetrazole derivatives
WO2010001257A3 (fr) Nouvelles formes à l’état solide de laquinimod et son sel de sodium
WO2005062897A3 (fr) Formes polymorphes d'ezetimibe et procedes de preparation de celles-ci
WO2009047775A3 (fr) Polymorphes de sels de l'ésoméprazole
TW200420541A (en) Crystalline forms
WO2006035277A3 (fr) Nouvelles methodes de preparation de calcium de rosuvastatine amorphe et nouvelle forme polymorphe de sodium de rosuvastatine
IL183591A0 (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
IL180311A0 (en) Process for the preparation of 4,4-difluoro-3-oxobutanoic acid esters
WO2007118873A3 (fr) Polymorphes de sels d'atorvastatine
ZA200701016B (en) Process for the preparation of isothiazole derivatives
WO2008117305A3 (fr) Nouveau procédé pour préparer de la prégabaline et ses sels d'addition avec les acides
AU2003290269A1 (en) Process for the production of synthetic magnesium silicate compositions
WO2008034912A3 (fr) Procédé de synthèse du clopidogrel et nouvelles formes de sels pharmaceutiquement acceptables de celui-ci
AU2003238671A1 (en) Novel crystalline forms of s-omeprazole magnesium
PL1737820T3 (pl) Sposób asymetrycznego uwodorniania nadający się do wytwarzania pochodnych cykloalkanoindoli
IL186499A (en) Processes for the preparation of a crystalline form of atorostatin mycelium
WO2006066044A3 (fr) Procedes de production de 4-aminoquinazolines
WO2005056563A3 (fr) Procedes
WO2008006720A3 (fr) Chlorhydrate de némorubicine cristallin
FR2894596B1 (fr) Procede d'autocalibration de biopuces
WO2007029096A3 (fr) Nouvelles formes polymorphes de chlorhydrate de clopidogrel
AU2003300727A1 (en) Process for synthesis of alpha-substituted acroleins
EP1863775A4 (fr) Procede de preparation d'une forme cristalline i d'olanzapine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06820751

Country of ref document: EP

Kind code of ref document: A2